Literature DB >> 30361387

Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells.

Stéphanie Liénart1, Romain Merceron2,3, Christophe Vanderaa1, Fanny Lambert1, Didier Colau4, Julie Stockis1,5, Bas van der Woning6, Hans De Haard6, Michael Saunders6, Pierre G Coulie1,5, Savvas N Savvides7,3, Sophie Lucas8,5.   

Abstract

Transforming growth factor-β1 (TGF-β1) is one of very few cytokines produced in a latent form, requiring activation to exert any of its vastly diverse effects on development, immunity, and cancer. Regulatory T cells (Tregs) suppress immune cells within close proximity by activating latent TGF-β1 presented by GARP (glycoprotein A repetitions predominant) to integrin αVβ8 on their surface. We solved the crystal structure of GARP:latent TGF-β1 bound to an antibody that stabilizes the complex and blocks release of active TGF-β1. This finding reveals how GARP exploits an unusual medley of interactions, including fold complementation by the amino terminus of TGF-β1, to chaperone and orient the cytokine for binding and activation by αVβ8. Thus, this work further elucidates the mechanism of antibody-mediated blockade of TGF-β1 activation and immunosuppression by Tregs.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30361387     DOI: 10.1126/science.aau2909

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  54 in total

Review 1.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

Review 2.  Specificity, versatility, and control of TGF-β family signaling.

Authors:  Rik Derynck; Erine H Budi
Journal:  Sci Signal       Date:  2019-02-26       Impact factor: 8.192

3.  GARP Dampens Cancer Immunity by Sustaining Function and Accumulation of Regulatory T Cells in the Colon.

Authors:  Mohammad Salem; Caroline Wallace; Maria Velegraki; Anqi Li; Ephraim Ansa-Addo; Alessandra Metelli; Hyunwoo Kwon; Brian Riesenberg; Bill Wu; Yongliang Zhang; Silvia Guglietta; Shaoli Sun; Bei Liu; Zihai Li
Journal:  Cancer Res       Date:  2019-01-23       Impact factor: 12.701

4.  Structural biology of the TGFβ family.

Authors:  Erich J Goebel; Kaitlin N Hart; Jason C McCoy; Thomas B Thompson
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-09

Review 5.  αvβ8 integrin adhesion and signaling pathways in development, physiology and disease.

Authors:  Joseph H McCarty
Journal:  J Cell Sci       Date:  2020-06-15       Impact factor: 5.285

6.  Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β.

Authors:  Alessandra Metelli; Bill X Wu; Brian Riesenberg; Silvia Guglietta; John D Huck; Catherine Mills; Anqi Li; Saleh Rachidi; Carsten Krieg; Mark P Rubinstein; Daniel T Gewirth; Shaoli Sun; Michael B Lilly; Amy H Wahlquist; David P Carbone; Yiping Yang; Bei Liu; Zihai Li
Journal:  Sci Transl Med       Date:  2020-01-08       Impact factor: 17.956

7.  Bi-allelic LoF NRROS Variants Impairing Active TGF-β1 Delivery Cause a Severe Infantile-Onset Neurodegenerative Condition with Intracranial Calcification.

Authors:  Xiaomin Dong; Natalie B Tan; Katherine B Howell; Sabina Barresi; Jeremy L Freeman; Davide Vecchio; Maria Piccione; Francesca Clementina Radio; Daniel Calame; Shan Zong; Stefanie Eggers; Ingrid E Scheffer; Tiong Y Tan; Nicole J Van Bergen; Marco Tartaglia; John Christodoulou; Susan M White
Journal:  Am J Hum Genet       Date:  2020-03-19       Impact factor: 11.025

8.  Cryo-EM Reveals Integrin-Mediated TGF-β Activation without Release from Latent TGF-β.

Authors:  Melody G Campbell; Anthony Cormier; Saburo Ito; Robert I Seed; Andrew J Bondesson; Jianlong Lou; James D Marks; Jody L Baron; Yifan Cheng; Stephen L Nishimura
Journal:  Cell       Date:  2020-01-16       Impact factor: 41.582

9.  Cryopreservation timing is a critical process parameter in a thymic regulatory T-cell therapy manufacturing protocol.

Authors:  Katherine N MacDonald; Sabine Ivison; Keli L Hippen; Romy E Hoeppli; Michael Hall; Grace Zheng; I Esme Dijke; Mohammed Al Aklabi; Darren H Freed; Ivan Rebeyka; Sanjiv Gandhi; Lori J West; James M Piret; Bruce R Blazar; Megan K Levings
Journal:  Cytotherapy       Date:  2019-12-03       Impact factor: 5.414

10.  A tumor-specific mechanism of Treg enrichment mediated by the integrin αvβ8.

Authors:  Robert I Seed; Kenji Kobayashi; Saburo Ito; Naoki Takasaka; Anthony Cormier; Jillian M Jespersen; Jean Publicover; Suprita Trilok; Alexis J Combes; Nayvin W Chew; Jocelyne Chapman; Matthew F Krummel; Jianlong Lou; James Marks; Yifan Cheng; Jody L Baron; Stephen L Nishimura
Journal:  Sci Immunol       Date:  2021-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.